Correction inevitable, to come in handy for exporters

Even as the rupee closed at a new historic low of 86.58 against the US dollar on Monday, the steepest single-day fall in nearly two years, economists maintained that this was an adjustment that was both warranted and inevitable. The rupee is overvalued and there is a need for the Reserve Bank of India to step back a bit and let it adjust, they said.

For exporters, this could be a boon, but a lot will depend on movements of the currencies of countries that are competing with India. The export sectors that can hope to reap benefits are those where the local content dominates like cotton textiles, leather and agriculture products. This augurs well as the share of some of the labour-intensive sectors in India’s exports has been falling.

Expectations of a further depreciation and the three-month forward rates that are around Rs 70 to a dollar can allow space for exporters negotiating new orders to offer better rates, analysts said. “India’s basic balance of payments deficit is widening when portfolio inflows and the domestic economy have slowed. The rupee is overvalued,”  said Dhiraj Nim, economist at ANZ Research.

Also ReadUpcoming listing: THESE 5 IPOs to list tomorrow – What does the GMP indicate

Compared with Southeast Asian currencies, the rupee remains relatively stable, but its moves are now increasingly in line with regional currencies. The rupee’s earlier stability against depreciating regional peers over 2024 had resulted in bilateral appreciation and loss of competitiveness, Nim observed. “In the calendar year 2025 so far, the rupee has depreciated 1% against the dollar, ranking 3rd among 23 emerging market peers,” Garima Kapoor, an economist at Elara Securities, said.

Engineering Export Promotion Council chairman Pankaj Chadha said: “Only beneficiary of the falling rupee would be exporters who are getting payments now or are shipping out orders contracted earlier. Those who have not hedged their receivables may reap a windfall. However, such gains typically last for 10-120 days only, as in new contracts, buyers will drive down prices based on the exchange rate outlook prevailing then.”

“Those who have made advance billing of rice exports would immensely benefit from a decline in the value of the rupee against the dollar,” said Vijay Setia, managing director, Chaman Lal Setia exports,

 » Read More

Related Articles

Trump tariff impact: Pharma stocks surge over 4% on tariff exemption

It’s a party for pharma stocks on Dalal Street. The Nifty Pharma Index is up nearly 4% and Sun Pharma, Gland Pharma and IPCA Labs see gains close to 4% each. Even Lupin and Natco Pharma are rallying smartly. In a major relief, Indian pharmaceutical companies breathed a sigh of relief after US President Donald

Trump tariff impact: Tech stocks plummet, Nifty IT cracks 2.5%

The share price of IT stocks slumped after US President Donald Trump’s administration imposed 26% reciprocal tariffs on Indian imports to the US. The Nifty IT, a basket of Indian tech stocks, fell 2.5% to 35,371.55 levels.  All the constituents of the sectoral index were trading in the red. The share price of Persistent Systems

Trump tariffs send shockwaves across global markets; US futures crash, gold soars to new highs- 10 cues you need to track now

Indian stock markets are set for a turbulent start as global jitters over Trump’s new tariffs weigh on. Early trends from GIFT Nifty point to a sharp drop of over 350 points, signaling a weak opening for Sensex and Nifty 50. Indian stock markets ended on a positive note in the previous trading session, with

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

Trump tariff impact: Pharma stocks surge over 4% on tariff exemption

It’s a party for pharma stocks on Dalal Street. The Nifty Pharma Index is up nearly 4% and Sun Pharma, Gland Pharma and IPCA Labs see gains close to 4% each. Even Lupin and Natco Pharma are rallying smartly. In a major relief, Indian pharmaceutical companies breathed a sigh of relief after US President Donald

Trump tariff impact: Tech stocks plummet, Nifty IT cracks 2.5%

The share price of IT stocks slumped after US President Donald Trump’s administration imposed 26% reciprocal tariffs on Indian imports to the US. The Nifty IT, a basket of Indian tech stocks, fell 2.5% to 35,371.55 levels.  All the constituents of the sectoral index were trading in the red. The share price of Persistent Systems

Trump tariffs send shockwaves across global markets; US futures crash, gold soars to new highs- 10 cues you need to track now

Indian stock markets are set for a turbulent start as global jitters over Trump’s new tariffs weigh on. Early trends from GIFT Nifty point to a sharp drop of over 350 points, signaling a weak opening for Sensex and Nifty 50. Indian stock markets ended on a positive note in the previous trading session, with

‘Pramerica Life targets Rs 3,000-crore GWP in FY26,’ Pankaj Gupta

Pramerica Life Insurance, a joint venture between subsidiaries of Piramal Capital and Housing Finance and US-based Prudential Financial Inc, aims to close FY26 with Rs 3,000 crore in gross written premium. In an interview with Narayanan V, managing director and CEO Pankaj Gupta discusses the products and distribution strategy. Excerpts: Life insurance premiums have been

Tata small cap fund: Targeting growth at reasonable valuations

Tata Small Cap Fund is a growth-oriented scheme in the Small Cap Fund category that has exhibited a noteworthy track record since its inception and has outpaced many of its prominent peers, thereby rewarding investors with superior risk-adjusted returns. Launched in November 2018, Tata Small Cap Fund aims to invest in stocks of companies that are in growth